Difference between revisions of "Test"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 66: | Line 66: | ||
- [[Myeloid Neoplasms with Germline ETV6 Mutation]] | - [[Myeloid Neoplasms with Germline ETV6 Mutation]] | ||
- [[Myeloid Neoplasms with Germline GATA2 Mutation]] | - [[Myeloid Neoplasms with Germline GATA2 Mutation]] | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia]] | ||
| + | *[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)]] | ||
| + | *[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia]] | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia]] | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Excess Blasts]] | ||
| + | *[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)]] | ||
| + | *[[Myelodysplastic Syndrome (MDS), Unclassifiable]] | ||
| + | *[[Refractory Cytopenia of Childhood]] | ||
Revision as of 15:24, 14 February 2021
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- Recurrent Genetic Abnormalities
- t(8;21)(q22;q22.1); RUNX1-RUNX1T1
- Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
- Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes
- sub division
- sub-sub-sub division
- sub division
- Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 - Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - Acute Promyelocytic Leukemia (APL) with PML-RARA - Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 - Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 - Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM - Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 - Acute Myeloid Leukemia (AML) with BCR-ABL1 - Acute Myeloid Leukemia (AML) with Mutated NPM1 - Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA - Acute Myeloid Leukemia (AML) with Mutated RUNX1
- Acute Myeloid Leukemia (AML) with Minimal Differentiation - Acute Myeloid Leukemia (AML) without Maturation - Acute Myeloid Leukemia (AML) with Maturation - Acute Myelomonocytic Leukemia - Acute Monoblastic and Monocytic Leukemia - Pure Erythroid Leukemia - Acute Megakaryoblastic Leukemia (AMKL) - Acute Basophilic Leukemia - Acute Panmyelosis with Myelofibrosis
- Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome - Myeloid Leukemia Associated with Down Syndrome
- Acute Undifferentiated Leukemia - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)
- Acute Myeloid Leukaemia with Germline CEBPA Mutation - Myeloid Neoplasms with Germline DDX41 Mutation - Myeloid Neoplasms with Germline RUNX1 Mutation - Myeloid Neoplasms with Germline ANKRD26 Mutation - Myeloid Neoplasms with Germline ETV6 Mutation - Myeloid Neoplasms with Germline GATA2 Mutation
- Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia
- Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)
- Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia
- Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia
- Myelodysplastic Syndrome (MDS) with Excess Blasts
- Myelodysplastic Syndrome (MDS) with Isolated del(5q)
- Myelodysplastic Syndrome (MDS), Unclassifiable
- Refractory Cytopenia of Childhood